WHO launches Global Clinical Trials Forum
The Forum responds to World Health Assembly resolution WHA75.8, which called on WHO to improve the quality and coordination of clinical trials to generate high-quality evidence for health decision-making.
Indian Council Of Medical Research | 08/10/2025 | By Dineshwori
Monitor NDMA Impurity in Ranitidine Formulation: DCGI Directs Indian Drugmakers
The DCGI has instructed drug controllers of all States and Union Territories to ensure that manufacturers under their jurisdiction monitor the presence of N-Nitrosodimethylamine(NDMA) - a potentially carcinogenic impurity – in the active pharmaceutical ingredient (API) and formulation of the antacid Ranitidine.
Indian Council Of Medical Research | 31/07/2025 | By Dineshwori | 141
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy